Wedbush Securities’s Bionano Genomics BNGO Stock Holding History

Wedbush Securities’s Portfolio BNGO Stock Details BNGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-67	Closed	-$26K	–	883
2020 Q3	$26K	Buy	+67	New	+$26K	﹤0.01%	916

Other funds holding BNGO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank Julius Baer & Co Zurich, Switzerland $33.2B AUM 25.01% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

ECM

ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wedbush Securities's BNGO Position: Q4 2020 in Review

Wedbush Securities sold out of Bionano Genomics (BNGO) in Q4 2020, closing a stake of 67 shares — an estimated $26K sold.

Wedbush Securities first reported a position in BNGO in Q3 2020 and held it in 1 quarter. The position peaked at $26K in Q3 2020. 48 funds tracked by Wall St. Rank hold BNGO as of Q4 2020.

Wedbush Securities reported no remaining Bionano Genomics position as of Q4 2020 after selling out during the quarter.
Wedbush Securities sold 67 Bionano Genomics shares in Q4 2020, an estimated $26K.
Wedbush Securities first reported a position in Bionano Genomics in Q3 2020 and held it in 1 quarter.
Wedbush Securities's Bionano Genomics position peaked at $26K in Q3 2020.
48 funds tracked by Wall St. Rank held Bionano Genomics as of Q4 2020.

Based on Wedbush Securities's 13F filing for Q4 2020, filed 16 Feb 2021.